CBIZ (CBZ)
NYSE:CBZ
Want to see CBZ full AI Analyst Report?
Top Page
CBIZ
(NYSE:CBZ)
Select Model
Select Model
Rating:67Neutral
Price Target:
$35.00
▲(16.67% Upside)
Action:Reiterated
Date:05/16/26
The score is primarily supported by solid financial performance (growth and free cash flow) and a very low P/E valuation, while elevated leverage and weak longer-term technical trends meaningfully temper the outlook. Earnings call tone was constructive with raised EPS guidance and a deleveraging plan, but integration drag and limited near-term margin expansion remain key risks.
Positive Factors
Revenue Growth Momentum
Sustained, multi-year revenue expansion demonstrates successful scaling of CBIZ’s fee and commission-based services and cross-sell model across a national platform. Robust top-line growth supports investment in systems, talent and deleveraging while reducing reliance on any single revenue source.
Negative Factors
Elevated Leverage
Material debt increase has pushed leverage to levels that heighten sensitivity to margin or revenue shocks and constrain strategic flexibility. Meeting the stated <2.5x target requires sustained strong cash generation; failure to delever would limit M&A optionality and capital return programs.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Momentum
Sustained, multi-year revenue expansion demonstrates successful scaling of CBIZ’s fee and commission-based services and cross-sell model across a national platform. Robust top-line growth supports investment in systems, talent and deleveraging while reducing reliance on any single revenue source.
Read all positive factors
CBIZ (CBZ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.72B
Dividend YieldN/A
Average Volume (3M)641.89K
Price to Earnings (P/E)2.6
Beta (1Y)1.03
Revenue Growth28.34%
EPS Growth67.93%
CountryUS
Employees10,000
SectorIndustrials
Sector Strength72
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)2.54
Shares Outstanding53,648,730
10 Day Avg. Volume591,514
30 Day Avg. Volume641,893
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.81
Price to Sales (P/S)1.16
P/FCF Ratio18.18
Enterprise Value/Market Cap2.15
Enterprise Value/Revenue1.33
Enterprise Value/Gross Profit10.45
Enterprise Value/Ebitda7.86
Forecast
1Y Price Target
$38.00Price Target Upside26.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)4.07
Revenue Forecast (FY)$2.84B
CBIZ Business Overview & Revenue Model
Company Description
CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. The company operates through three segments: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services segme...
How the Company Makes Money
CBIZ makes money primarily by charging fees and commissions for professional services delivered through two main operating areas: (1) Financial Services and (2) Benefits & Insurance Services. In Financial Services, revenue is largely fee-based and...
CBIZ Earnings Call Summary
Earnings Call Date:Apr 29, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Jul 23, 2026
Earnings Call Sentiment Positive
The call highlights a solid start to the year with revenue growth, EPS improvement, meaningful free cash flow generation and active share repurchases, plus strategic progress on AI, offshoring and industry verticalization. Key challenges include a 4% decline in Benefits & Insurance revenue driven by a producer departure and contingent commission weakness, temporary integration-related drag estimated to have shaved ~200 bps off Q1 organic growth, and a portion of the free cash flow improvement being one-time. Management reaffirmed guidance, raised EPS outlook, and outlined a path to margin expansion and deleveraging as integration issues abate and AI/offshoring efficiencies scale.Positive Updates
Consolidated Revenue Growth
Consolidated revenue of $849 million, up 1.3% year-over-year; reported organic revenue growth of 1% for Q1.
Negative Updates
Benefits & Insurance Revenue Decline
B&I revenue was $108 million, down 4% year-over-year; declines driven by tough comps on project-related work and contingent commissions, and the unexpected departure of a single producer and his team in February.
Read all updates
Q1-2026 Updates
Positive
Negative
Consolidated Revenue Growth
Consolidated revenue of $849 million, up 1.3% year-over-year; reported organic revenue growth of 1% for Q1.
Read all positive updates
Company Guidance
CBIZ reaffirmed 2026 guidance of revenue $2.8–$2.9 billion (2%–5% YoY), adjusted EBITDA $465–$475 million, and raised adjusted EPS to $4.00–$4.10 per share (assumes ~60.5 million weighted‑average diluted shares); free cash flow guidance remains $270–$290 million (≈60% conversion at the midpoint). Management highlighted a solid start to the year with Q1 consolidated revenue of $849 million (+1.3% YoY; organic +1%), adjusted EBITDA of $244 million (adj. margin +10 bps), adjusted diluted EPS $2.50 (+7% YoY), free cash flow improvement of $64 million (including $53 million final purchase price adjustment), and net leverage of ~3.4x (down from ~3.9x a year ago). They estimate Q1 Financial Services organic growth was reduced by ~200 bps due to prior client exits (ex‑impact FS organic would be ~4%), expect those impacts to abate by H2, plan to exit 2026 at mid‑single‑digit organic growth and to return to their long‑term growth algorithm, and reiterated capital priorities: fund organic/maintenance capex, delever to <2.5x by 2027, and remain opportunistic on buybacks (≈2 million shares repurchased YTD; ~$63 million repurchased through April), while pursuing operational efficiencies (AI rollouts, offshoring from ~6% in 2025 → 10% in 2026 and >20% over time).CBIZ Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
52
Neutral
Cash Flow
71
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.77B | 2.76B | 1.81B | 1.59B | 1.41B | 1.10B |
| Gross Profit | 353.31M | 355.39M | 182.47M | 223.20M | 223.37M | 159.29M |
| EBITDA | 469.71M | 366.32M | 140.25M | 222.70M | 182.41M | 123.96M |
| Net Income | 154.28M | 115.44M | 41.04M | 120.97M | 105.35M | 70.89M |
Balance Sheet | ||||||
| Total Assets | 4.63B | 4.58B | 4.47B | 2.04B | 1.93B | 1.67B |
| Cash, Cash Equivalents and Short-Term Investments | 28.72M | 56.52M | 13.83M | 8.09M | 33.18M | 32.38M |
| Total Debt | 1.99B | 1.83B | 1.83B | 551.01M | 474.47M | 331.25M |
| Total Liabilities | 2.74B | 2.82B | 2.69B | 1.25B | 1.21B | 968.17M |
| Stockholders Equity | 1.89B | 1.76B | 1.78B | 791.62M | 713.45M | 704.55M |
Cash Flow | ||||||
| Free Cash Flow | 239.11M | 175.53M | 110.78M | 130.46M | 117.49M | 122.17M |
| Operating Cash Flow | 255.24M | 192.49M | 123.69M | 153.51M | 126.13M | 131.15M |
| Investing Cash Flow | -13.81M | -15.85M | -1.13B | -79.39M | -99.12M | -82.01M |
| Financing Cash Flow | -213.65M | -145.71M | 1.04B | -77.11M | -17.34M | -69.00M |
CBIZ Technical Analysis
Neutral
30.00
Price Trends
29.09
Positive
33.65
Negative
44.44
Negative
Market Momentum
0.42
Negative
58.76
Neutral
91.67
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CBZ, the sentiment is Neutral. The current price of 30 is below the 20-day moving average (MA) of 30.91, above the 50-day MA of 29.09, and below the 200-day MA of 44.44, indicating a neutral trend. The MACD of 0.42 indicates Negative momentum. The RSI at 58.76 is Neutral, neither overbought nor oversold. The STOCH value of 91.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CBZ.
CBIZ Risk Analysis
CBIZ disclosed 43 risk factors in its most recent earnings report. CBIZ reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
CBIZ Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $3.23B | 8.91 | 21.75% | 1.38% | -1.44% | 33.09% | |
69 Neutral | $4.60B | 49.97 | 6.24% | 0.71% | 0.76% | -8.22% | |
68 Neutral | $2.58B | 235.83 | 0.66% | ― | 53.53% | ― | |
68 Neutral | $1.11B | 224.52 | 6.38% | ― | 12.87% | -63.11% | |
67 Neutral | $1.72B | 2.56 | 8.32% | ― | 28.34% | 67.93% | |
65 Neutral | $2.35B | 17.89 | 8.80% | 2.20% | 5.59% | 100.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
* Industrials Sector Average
CBZ
CBIZ
32.23
-39.70
-55.19%
ABM
ABM Industries
40.19
-9.59
-19.26%
MMS
Maximus
61.17
-9.99
-14.04%
UNF
UniFirst
265.47
83.35
45.76%
FA
First Advantage
15.42
-1.46
-8.65%
LZ
LegalZoom
6.36
-2.92
-31.47%
CBIZ Corporate Events
Executive/Board ChangesShareholder Meetings
CBIZ Shareholders Back Directors, Auditor and Executive Pay
Positive
May 15, 2026
At its annual meeting of stockholders held on May 14, 2026, CBIZ, Inc. shareholders elected Richard T. Marabito and Rodney A. Young to the board of directors, with both nominees receiving strong majority support despite a modest level of oppositio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.